Test-retest reliability of DSM-5 substance disorder measures as assessed with the PRISM-5, a clinician-administered diagnostic interview.
DSM-5
Dependence
Reliability
Substance use disorders
Test-restest
Journal
Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587
Informations de publication
Date de publication:
01 11 2020
01 11 2020
Historique:
received:
02
04
2020
revised:
09
09
2020
accepted:
10
09
2020
pubmed:
3
10
2020
medline:
14
4
2021
entrez:
2
10
2020
Statut:
ppublish
Résumé
In DSM-5, the definitions of substance use disorders (SUD) were changed considerably, yet little is known about the reliability of DSM-5 SUD and its new features. The test-retest reliability of DSM-5 SUD and DSM-IV substance dependence (SD) was evaluated in 565 adult substance users, each interviewed twice by different clinician interviewers using the semi-structured Psychiatric Research Interview for Substance and Mental Disorders, DSM-5 version (PRISM-5). DSM-5 SUD and DSM-IV SD criteria were assessed for past year and lifetime, yielding diagnoses and severity levels for alcohol, tobacco, cannabis, cocaine, heroin, opioids, sedatives, hallucinogen, and stimulant use disorders. Cohen's and intraclass correlation coefficients (ICC) assessed reliability for categorical and graded outcomes, respectively. Factors potentially influencing reliability were explored, including inpatient vs. community participant, days between interviews gender, age, race/ethnicity, and SUD severity. DSM-5 SUD diagnoses had substantial to excellent reliability for most substances (κ = 0.63-0.94), and moderate for others (hallucinogens, stimulants, sedatives; κ = 0.50-0.59). For graded outcomes (DSM-5 SUD mild, moderate, severe; criteria count 0-11), reliability was substantial to excellent (ICC = 0.74-0.99). Comparisons of DSM-5 SUD and DSM-IV SD reliability showed few significant differences. Reliability of the DSM-5 craving criterion was excellent for heroin (κ = 0.84-0.95) and moderate to substantial for other substances (κ = 0.49-0.76). The only factor influencing reliability of SUD was severity, with milder disorders significantly more likely to be discordant between the interviews. Reproducibility is crucial to good measurement. In a large sample using rigorous methodology, diagnoses and dimensional measures from clinician-administered interviews for DSM-5 SUD were generally highly reliable.
Identifiants
pubmed: 33007702
pii: S0376-8716(20)30459-2
doi: 10.1016/j.drugalcdep.2020.108294
pmc: PMC7663179
mid: NIHMS1642169
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
108294Subventions
Organisme : NIDA NIH HHS
ID : R01 DA018652
Pays : United States
Informations de copyright
Copyright © 2020. Published by Elsevier B.V.
Références
NCHS Data Brief. 2015 Feb;(189):1-8
pubmed: 25714043
Am J Psychiatry. 2013 Aug;170(8):834-51
pubmed: 23903334
Addict Behav. 2019 Mar;90:250-257
pubmed: 30471553
Curr Opin Psychol. 2019 Dec;30:98-102
pubmed: 31071592
Drug Alcohol Depend. 2015 Aug 1;153:229-35
pubmed: 26048641
Addiction. 2000 Aug;95 Suppl 2:S189-210
pubmed: 11002914
Psychol Bull. 1979 Mar;86(2):420-8
pubmed: 18839484
Am J Psychiatry. 2004 Nov;161(11):1967-77
pubmed: 15514394
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
JAMA Psychiatry. 2016 Jan;73(1):39-47
pubmed: 26580136
NCHS Data Brief. 2018 Nov;(329):1-8
pubmed: 30500323
Am J Psychiatry. 2006 Apr;163(4):689-96
pubmed: 16585445
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Am J Psychiatry. 2004 Jul;161(7):1231-7
pubmed: 15229056
Natl Vital Stat Rep. 2019 Mar;68(3):1-19
pubmed: 31112123
Can J Psychiatry. 2020 Feb;65(2):87-98
pubmed: 31747307
Drug Alcohol Depend. 2019 Dec 1;205:107590
pubmed: 31600616
Am J Psychiatry. 1996 Sep;153(9):1195-201
pubmed: 8780425
Drug Alcohol Depend. 1997 Sep 25;47(3):217-26
pubmed: 9306047
Curr Psychiatry Rep. 2019 Feb 7;21(2):10
pubmed: 30729322
Curr Opin Neurobiol. 2013 Aug;23(4):649-54
pubmed: 23764204
Drug Alcohol Depend. 2015 Mar 1;148:40-6
pubmed: 25604321
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):5-15
pubmed: 30671616
Am J Drug Alcohol Abuse. 2019;45(6):623-643
pubmed: 30870044
Addiction. 1993 Aug;88(8):1071-7
pubmed: 8401161
Drug Alcohol Depend. 1995 Jul;39(1):37-44
pubmed: 7587973
Drug Alcohol Depend. 2015 Mar 1;148:27-33
pubmed: 25595052
Drug Alcohol Depend. 2012 Apr 1;122(1-2):28-37
pubmed: 21963333
MMWR Morb Mortal Wkly Rep. 2019 May 03;68(17):388-395
pubmed: 31048676
Psychol Med. 2013 Oct;43(10):2179-90
pubmed: 23312475
MMWR Morb Mortal Wkly Rep. 2018 Jan 04;67(5152):1419-1427
pubmed: 30605448
Addiction. 2000 Aug;95 Suppl 2:S211-7
pubmed: 11002915
Neuropsychopharmacology. 2018 Jan;43(1):195-212
pubmed: 28853439
Psychol Med. 2011 Mar;41(3):629-40
pubmed: 20459881
J Forensic Sci. 2010 Sep;55(5):1209-17
pubmed: 20487147
Br J Addict. 1992 Feb;87(2):309-16
pubmed: 1555008
Addiction. 2006 Sep;101 Suppl 1:59-75
pubmed: 16930162
Int J Methods Psychiatr Res. 2006;15(3):131-8
pubmed: 17019897
Alcohol Alcohol. 1999 Mar-Apr;34(2):223-30
pubmed: 10344782
JAMA Psychiatry. 2017 May 1;74(5):445-455
pubmed: 28355458
JAMA Psychiatry. 2020 Feb 1;77(2):165-171
pubmed: 31722000
Biol Psychiatry. 2016 Apr 1;79(7):613-9
pubmed: 26903403
J Clin Psychiatry. 2016 Jun;77(6):772-80
pubmed: 27337416
Psychopharmacol Bull. 1998;34(1):3-8
pubmed: 9564191
Psychol Med. 2013 Sep;43(9):1793-800
pubmed: 23822994
Drug Alcohol Depend. 1997 Mar 14;44(2-3):133-41
pubmed: 9088785
JAMA Psychiatry. 2015 Aug;72(8):757-66
pubmed: 26039070